# Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease

> **NCT02563184** · PHASE4 · UNKNOWN · sponsor: **Banner Health** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **BIOLOGICAL:** Fluzone

## Key facts

- **NCT ID:** NCT02563184
- **Lead sponsor:** Banner Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02563184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02563184, "Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02563184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*